Zejula

(niraparib)
niraparib 100 MG Oral Capsule [Zejula]
NO BLACK BOX WARNING

Dosage & administration

Most viewed Zejula resources

Enroll in Patient Savings Program

biomarker testing

Zejula clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Zejula prescribing information

samples

Request Zejula samples

Online Sample Form
Learn More

prior authorization

Zejula prior authorization resources

PDF
Complete Letter of Medical Necessity

PDF
Coverage Authorization Appeals
Learn More

Benefits investigation

PDF
Zejula Service Request Form
Learn More

financial assistance

Zejula financial assistance options

Co-pay savings program

commercial only

PDF
Zejula Service Request Form
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only

PDF
Zejula Service Request Form

OTHER
Quick Start & Bridge Program
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+

PDF
Zejula Service Request Form

OTHER
GSK Patient Assistance Program Eligibiligy & Enrollment
Learn More

patient education

Zejula patient education

Getting started on Zejula

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

PDF
Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Learn More

people also ask

Zejula FAQs

How is the dosage of Zejula?Zejula is available in 1 dosages, including 100 mg Cap
What does Zejula treat?Zejula treats Fallopian Tube Neoplasms, Ovarian Neoplasms and Peritoneal Neoplasms
What is Zejula made of?Zejula contains niraparib which is a Poly(ADP-Ribose) Polymerase Inhibitor
How Is Zejula Administered?Zejula is administered as a Oral Pill
What Are The Zejula Mechanism Of Action?Zejula mechanism of action is Poly(ADP-Ribose) Polymerase Inhibitors
FAQ Data Source